Supplementation of L-carnitine in athletes: Does it make sense?

Nutrition

Volumn 20, Issue 7-8, 2004, Pages 709-715

  Karlic, Heidrun ^a   Lohninger, Alfred ^b  

^a HANUSCH HOSPITAL   (Austria)

^b NONE

Author keywords

exercise; L carnitine supplementation; metabolism

Indexed keywords

CARNITINE; COENZYME A; LYSINE; METHIONINE;

APOPTOSIS; ATHLETE; CELL DAMAGE; COMPETITION; DIET SUPPLEMENTATION; ENDURANCE; EXERCISE; FATTY ACID ANALYSIS; GENE CONTROL; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; IMMUNE SYSTEM; LIPID METABOLISM; MITOCHONDRIAL RESPIRATION; OXYGEN CONSUMPTION; PERFORMANCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; SAFETY; SKELETAL MUSCLE; STRESS; TRAINING; WEIGHT REDUCTION;

APOPTOSIS; CARNITINE; COENZYME A; COLLAGEN; DIETARY SUPPLEMENTS; EXERCISE; HEMATOPOIESIS; HUMANS; IMMUNITY; LACTIC ACID; LIPID METABOLISM; OXYGEN CONSUMPTION; PLATELET AGGREGATION; SPORTS; WEIGHT LOSS;

EID: 2942707816     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2004.04.003     Document Type: Review

References (93)

1. Cerretelli P., Marconi C. L-carnitine supplementation in humans. The effects on physical performance. Int J Sports Med. 11:1990;1
2. Rebouche C.J., Chenard C.A. Metabolic fate of dietary carnitine in human adults identification and quantification of urinary and fecal metabolites. J Nutr. 121:1991;539
3. Gulewitsch W.K.R. Zur Kenntnis der Extraktionsstoffe der Muskeln. 2. Mitteilungen über das Carnitin (extracted substances in muscle, report on carnitine). Hoppe-Seyler Z Physiol Chem. 45:1905;326
4. Strack E., Neubauer E., Geissendörfer H. Über den Gehalt von Cholin, Acetylcholin und Carnitin im Muskel (content of choline acetylcholine and carnitine in muscle). Hoppe-Seyler Z Physiol Chem. 233:1935;189
5. Fritz I.B. Action of carnitine on long chain fatty acid oxidation by liver. Am J Physiol. 197:1959;297
6. Lopes G., Bazotte R.B., Curi R., Alves-Do-Prado W. L- and DL-carnitine induce tetanic fade in rat neuromuscular preparation. Braz J Med Biol Res. 36:2003;1255
7. Siliprandi N., Di Lisa F., Menabo R. Clinical use of carnitine. Past, present and future. Adv Exp Med Biol. 272:1990;175
8. Brevetti G., Chiariello M., Ferulano G., et al. Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine a double-blind, cross-over study. Circulation. 77:1988;767
9. Vescovo G., Ravara B., Gobbo V., et al. L-carnitine a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure. Am J Physiol Cell Physiol. 283:2002;C802
10. Mutomba M.C., Yuan H., Konyavko M., et al. Regulation of the activity of caspases by L-carnitine and palmitoylcarnitine. FEBS Lett. 478:2000;19
11. Di Marzio L., Alesse E., Roncaioli P., et al. Influence of L-carnitine on CD95 cross-lining-induced apoptosis and ceramide generation in human cell lines correlation with its effects on purified acidic and neutral sphingomyelinases in vitro. Proc Assoc Am Phys. 109:1997;154
12. Karlic H., Lohninger A., Laschan C., et al. Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromes. J Mol Med. 81:2003;435
13. Brown H.R., Ni H., Benavides G., et al. Correlation of simultaneous differential gene expression in the blood and heart with known mechanisms of adriamycin-induced cardiomyopathy in the rat. Toxicol Pathol. 30:2002;452
14. Matera M., Bellinghieri G., Costantino G., Santoro D., Calvani M., Savica V. History of L-carnitine implications for renal disease. J Ren Nutr. 13:2003;2
15. Schoderbeck M., Auer B., Legenstein E., et al. Pregnancy-related changes of carnitine and acylcarnitine concentrations of plasma and erythrocytes. J Perinat Med. 23:1995;477
16. Bremer J. Carnitine - metabolism and functions. Physiol Rev. 63:1983;1420
17. Bieber L.L. Carnitine. Annu Rev Biochem. 57:1988;261
18. Berardi S., Stieger B., Wachter S., O'Neill B., Krahenbuhl S. Characterization of a sodium-dependent transport system for butyrobetaine into rat liver plasma membrane vesicles. Hepatology. 28:1998;521
19. Vaz F.M., Wanders R.J. Carnitine biosynthesis in mammals. Biochem J. 361:2002;417
20. Ramsay R.R., Gandour R.D., van der Leij F.R. Molecular enzymology of carnitine transfer and transport. Biochim Biophys Acta. 1546:2001;21
21. McGarry J.D., Brown N.F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem. 244:1997;1
22. Jeukendrup A.E. Regulation of fat metabolism in skeletal muscle. Ann NY Acad Sci. 967:2002;217
23. Claessens Y.E., Cariou A., Monchi M., et al. Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with L-carnitine. Crit Care Med. 31:2003;1042
24. Sweeney J.D., Blair A.J., Cheves T.A., Dottori S., Arduini A. L-carnitine decreases glycolysis in liquid-stored platelets. Transfusion. 40:2000;1313
25. Van Hall G. Lactate as a fuel for mitochondrial respiration. Acta Physiol Scand. 168:2000;643
26. Van Hall G., Gonzalez-Alonso J., Sacchetti M., Saltin B. Skeletal muscle substrate metabolism during exercise methodological considerations. Proc Nutr Soc. 58:1999;899
27. Bakker A., Biermans W., Van Belle H., De Bie M., Bernaert I., Jacob W. Ultrastructural localisation of carnitine acetyltransferase activity in mitochondria of rat myocardium. Biochim Biophys Acta. 1185:1994;97
28. Faergeman N.J., Knudsen J. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. Biochem J. 323:(pt 1):1997;1
29. Idell-Wenger J.A., Grotyohann L.W., Neely J.R. Regulation of fatty acid utilization in heart. Role of the carnitine-acetyl-CoA transferase and carnitine-acetyl carnitine translocase system. J Mol Cell Cardiol. 14:1982;413
30. Lysiak W., Lilly K., DiLisa F., Toth P.P., Bieber L.L. Quantitation of the effect of L- carnitine on the levels of acid-soluble short-chain acyl-CoA and CoASH in rat heart and liver mitochondria. J Biol Chem. 263:1988;1151
31. Abbas A.S., Wu G., Schulz H. Carnitine acetyltransferase is not a cytosolic enzyme in rat heart and therefore cannot function in the energy-linked regulation of cardiac fatty acid oxidation. J Mol Cell Cardiol. 30:1998;1305
32. Barnett C., Costill D.L., Vukovich M.D., et al. Effect of L-carnitine supplementation on muscle and blood carnitine content and lactate accumulation during high-intensity sprint cycling. Int J Sport Nutr. 4:1994;280
33. Villani R.G., Gannon J., Self M., Rich P.A. L-carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women. Int J Sport Nutr Exerc Metab. 10:2000;199
34. Walter P., Schaffhauser A.O. L-carnitine, a vitamin-like substance for functional food. Proceedings of the symposium on L-carnitine, April 28 to May 1, 2000, Zermatt, Switzerland. Ann Nutr Metab. 44:2000;75
35. Obici S., Feng Z., Arduini A., Conti R., Rossetti L. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med. 9:2003;756
36. Karlic H., Lohninger S., Koeck T., Lohninger A. Dietary L-carnitine stimulates carnitine acyltransferases in the liver of aged rats. J Histochem Cytochem. 50:2002;205
37. Alesci S., De Martino M.U., Mirani M., et al. L-carnitine a nutritional modulator of glucocorticoid receptor functions. FASEB J. 17:2003;1553
38. Lohninger A., Agu C.A., Hofbauer R., Nissel H., Karlic H. Carnitine and transcription of carnitine palmitoyltransferases - in vitro and in vivo studies. Richter V., Reuter W., Rassoul F., Thiery J. Lipoproteinmetabolismus und Atherosklerosepraevention. 2002;113 Wissenschaftliche Skripten, Zwickau, Leipzig
39. Hinderling V.B., Schrauwen P., Langhans W., Westerterp-Plantenga M.S. The effect of etomoxir on 24-h substrate oxidation and satiety in humans. Am J Clin Nutr. 76:2002;141
40. Jallon P., Picard F. Bodyweight gain and anticonvulsants a comparative review. Drug Saf. 24:2001;969
41. Vukovich M.D., Costill D.L., Fink W.J. Carnitine supplementation effect on muscle carnitine and glycogen content during exercise. Med Sci Sports Exerc. 26:1994;1122
42. Arenas J., Huertas R., Campos Y., Diaz A.E., Villalon J.M., Vilas E. Effects of L-carnitine on the pyruvate dehydrogenase complex and carnitine palmitoyl transferase activities in muscle of endurance athletes. FEBS Lett. 341:1994;91
43. Huertas R., Campos Y., Diaz E., et al. Respiratory chain enzymes in muscle of endurance athletes effect of L-carnitine. Biochem Biophys Res Commun. 188:1992;102
44. Wyss V., Ganzit G.P., Rienzi A. Effects of L-carnitine administration on VO2max and the aerobic-anaerobic threshold in normoxia and acute hypoxia. Eur J Appl Physiol Occup Physiol. 60:1990;1
45. Gorostiaga E.M., Maurer C.A., Eclache J.P. Decrease in respiratory quotient during exercise following L-carnitine supplementation. Int J Sports Med. 10:1989;169
46. Muller D.M., Seim H., Kiess W., Loster H., Richter T. Effects of oral L-carnitine supplementation on in vivo long-chain fatty acid oxidation in healthy adults. Metabolism. 51:2002;1389
47. Kraemer W.J., Volek J.S., French D.N., et al. The effects of L-carnitine L-tartrate supplementation on hormonal responses to resistance exercise and recovery. J Strength Cond Res. 17:2003;455
48. Volek J.S., Kraemer W.J., Rubin M.R., Gomez A.L., Ratamess N.A., Gaynor P. L-carnitine L-tartrate supplementation favorably affects markers of recovery from exercise stress. Am J Physiol Endocrinol Metab. 282:2002;E474
49. Brass E.P., Hiatt W.R. Carnitine metabolism during exercise. Life Sci. 54:1994;1383
50. Brass E.P. Supplemental carnitine and exercise. Am J Clin Nutr. 72:2000;618S
51. Romijn J.A., Coyle E.F., Sidossis L.S., et al. Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am J Physiol. 265:1993;E380
52. Hiatt W.R., Regensteiner J.G., Wolfel E.E., Ruff L., Brass E.P. Carnitine and acylcarnitine metabolism during exercise in humans. Dependence on skeletal muscle metabolic state. J Clin Invest. 84:1989;1167
53. Brass E.P., Hiatt W.R. The role of carnitine and carnitine supplementation during exercise in man and in individuals with special needs. J Am Coll Nutr. 17:1998;207
54. Giamberardino M.A., Dragani L., Valente R., Di Lisa F., Saggini R., Vecchiet L. Effects of prolonged L-carnitine administration on delayed muscle pain and CK release after eccentric effort. Int J Sports Med. 17:1996;320
55. Dragan I.G., Vasiliu A., Georgescu E., Eremia N. Studies concerning chronic and acute effects of L-carnitine in elite athletes. Physiologie. 26:1989;111
56. Dragan A.M., Vasiliu D., Eremia N.M., Georgescu E. Studies concerning some acute biological changes after endovenous administration of 1 g L-carnitine, in elite athletes. Physiologie. 24:1987;231
57. Dragan G.I., Wagner W., Ploesteanu E. Studies concerning the ergogenic value of protein supply and L-carnitine in elite junior cyclists. Physiologie. 25:1988;129
58. Vecchiet L., Di Lisa F., Pieralisi G., et al. Influence of L-carnitine administration on maximal physical exercise. Eur J Appl Physiol Occup Physiol. 61:1990;486
59. Arenas J., Ricoy J.R., Encinas A.R., et al. Carnitine in muscle, serum, and urine of nonprofessional athletes effects of physical exercise, training, and L-carnitine administration. Muscle Nerve. 14:1991;598
60. Marconi C., Sassi G., Carpinelli A., Cerretelli P. Effects of L-carnitine loading on the aerobic and anaerobic performance of endurance athletes. Eur J Appl Physiol Occup Physiol. 54:1985;131
61. Angelini A., Imparato L., Landi C., Porfido F.A., Ciarimboli M., Marro A. Variation in levels of glycaemia and insulin after infusion of glucose solutions with or without added L-carnitine. Drugs Exp Clin Res. 19:1993;219
62. Colombani P., Wenk C., Kunz I., et al. Effects of L-carnitine supplementation on physical performance and energy metabolism of endurance-trained athletes a double-blind crossover field study. Eur J Appl Physiol Occup Physiol. 73:1996;434
63. Nuesch R., Rossetto M., Martina B. Plasma and urine carnitine concentrations in well-trained athletes at rest and after exercise. Influence of L-carnitine intake. Drugs Exp Clin Res. 25:1999;167
64. Trappe S.W., Costill D.L., Goodpaster B., Vukovich M.D., Fink W.J. The effects of L-carnitine supplementation on performance during interval swimming. Int J Sports Med. 15:1994;181
65. Decombaz J., Deriaz O., Acheson K., Gmuender B., Jequier E. Effect of L-carnitine on submaximal exercise metabolism after depletion of muscle glycogen. Med Sci Sports Exerc. 25:1993;733
66. Soop M., Bjorkman O., Cederblad G., Hagenfeldt L., Wahren J. Influence of carnitine supplementation on muscle substrate and carnitine metabolism during exercise. J Appl Physiol. 64:1988;2394
67. Oyono-Enguelle S., Freund H., Ott C., et al. Prolonged submaximal exercise and L-carnitine in humans. Eur J Appl Physiol Occup Physiol. 58:1988;53
68. Casas H., Murtra B., Casas M., et al. Increased blood ammonia in hypoxia during exercise in humans. J Physiol Biochem. 57:2001;303
69. Yuan Y., So R., Wong S., Chan K.M. Ammonia threshold - comparison to lactate threshold, correlation to other physiological parameters and response to training. Scand J Med Sci Sports. 12:2002;358
70. Parolin M.L., Spriet L.L., Hultman E., Hollidge-Horvat M.G., Jones N.L., Heigenhauser G.J. Regulation of glycogen phosphorylase and PDH during exercise in human skeletal muscle during hypoxia. Am J Physiol Endocrinol Metab. 278:2000;E522
71. Gani F., Passalacqua G., Senna G., Mosca Frezet M. Sport, immune system and respiratory infections. Allerg Immunol (Paris). 35:2003;41
72. Gleeson M., Pyne D.B., Austin J.P., et al. Epstein-Barr virus reactivation and upper-respiratory illness in elite swimmers. Med Sci Sports Exerc. 34:2002;411
73. Gleeson M., McDonald W.A., Pyne D.B., et al. Immune status and respiratory illness for elite swimmers during a 12-week training cycle. Int J Sports Med. 21:2000;302
74. Gleeson M. Interleukins and exercise. J Physiol. 529:(pt 1):2000;1
75. Gleeson M. Mucosal immune responses and risk of respiratory illness in elite athletes. Exerc Immunol Rev. 6:2000;5
76. Gleeson M., Bishop N.C. Special feature for the Olympics effects of exercise on the immune system: modification of immune responses to exercise by carbohydrate, glutamine and anti-oxidant supplements. Immunol Cell Biol. 78:2000;554
77. Venkatraman J.T., Feng X., Pendergast D. Effects of dietary fat and endurance exercise on plasma cortisol, prostaglandin E2, interferon-gamma and lipid peroxides in runners. J Am Coll Nutr. 20:2001;529
78. Venkatraman J.T., Pendergast D. Effects of the level of dietary fat intake and endurance exercise on plasma cytokines in runners. Med Sci Sports Exerc. 30:1998;1198
79. Adlouni H.A., Katrib K., Ferard G. Changes in carnitine in polymorphonuclear leukocytes, mononuclear cells, and plasma from patients with inflammatory disorders. Clin Chem. 34:1988;40
80. Demirkol M., Sewell A.C., Bohles H. The variation of carnitine content in human blood cells during disease - a study in bacterial infection and inflammatory bowel disease. Eur J Pediatr. 153:1994;565
81. De Simone C., Famularo G., Tzantzoglou S., Trinchieri V., Moretti S., Sorice F. Carnitine depletion in peripheral blood mononuclear cells from patients with AIDS effect of oral L-carnitine. AIDS. 8:1994;655
82. De Simone C., Tzantzoglou S., Famularo G., et al. High dose L-carnitine improves immunologic and metabolic parameters in AIDS patients. Immunopharmacol Immunotoxicol. 15:1993;1
83. Franceschi C. Cell proliferation, cell death and aging. Aging (Milano). 1:1989;3
84. Matsumura M., Hatakeyama S., Koni I., Mabuchi H. Effect of L-carnitine and palmitoyl-L-carnitine on erythroid colony formation in fetal mouse liver cell culture. Am J Nephrol. 18:1998;355
85. Matsumoto Y., Amano I., Hirose S., et al. Effects of L-carnitine supplementation on renal anemia in poor responders to erythropoietin. Blood Purif. 19:2001;24
86. Moretti S., Alesse E., Di Marzio L., et al. Effect of L-carnitine on human immunodeficiency virus-1 infection-associated apoptosis a pilot study. Blood. 91:1998;3817
87. Pastorino J.G., Snyder J.W., Serroni A., Hoek J.B., Farber J.L. Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition. J Biol Chem. 268:1993;13791
88. Di Marzio L., Moretti S., D'Alo S., et al. Acetyl-L-carnitine administration increases insulin-like growth factor 1 levels in asymptomatic HIV-1-infected subjects correlation with its suppressive effect on lymphocyte apoptosis and ceramide generation. Clin Immunol. 92:1999;103
89. Wang L., Ma W., Markovich R., Chen J.W., Wang P.H. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circ Res. 83:1998;516
90. Pugazhenthi S., Miller E., Sable C., et al. Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein. J Biol Chem. 274:1999;27529
91. Wolff J.M.D., Strack E. Toxicity of L(-)-carnitine and various 0-acylcarnitines. (in German) Acta Biol Med Ger. 26:1971;1237
92. Sulkers E.J., Lafeber H.N., Degenhart H.J., Przyrembel H., Schlotzer E., Sauer P.J. Effects of high carnitine supplementation on substrate utilization in low-birth-weight infants receiving total parenteral nutrition. Am J Clin Nutr. 52:1990;889
93. Li B., Lloyd M.L., Gudjonsson H., Shug A.L., Olsen W.A. The effect of enteral carnitine administration in humans. Am J Clin Nutr. 55:1992;838